Literature DB >> 33508011

Understanding the relationship between safety beliefs and knowledge for cognitive enhancers in UK university students.

Ngoc Trai Nguyen1, Tim Rakow1, Benjamin Gardner1, Eleanor J Dommett1.   

Abstract

BACKGROUND: Cognitive enhancers (CE) are prescription drugs taken, either without a prescription or at a dose exceeding that which is prescribed, to improve cognitive functions such as concentration, vigilance or memory. Previous research suggests that users believe the drugs to be safer than non-users and that they have sufficient knowledge to judge safety. However, to date no research has compared the information sources used and safety knowledge of users and non-users.
OBJECTIVES: This study compared users and non-users of CE in terms of i) their sources of knowledge about the safety of CE and ii) the accuracy of their knowledge of possible adverse effects of a typical cognitive enhancer (modafinil); and iii) how the accuracy of knowledge relates to their safety beliefs.
METHODS: Students (N = 148) from King's College London (UK) completed an anonymous online survey assessing safety beliefs, sources of knowledge and knowledge of the safety of modafinil; and indicated whether they used CE, and, if so, which drug(s).
RESULTS: The belief that the drugs are safe was greater in users than non-users. However, both groups used comparable information sources and have similar, relatively poor drug safety knowledge. Furthermore, despite users more strongly believing in the safety of CE there was no relationship between their beliefs and knowledge, in contrast to non-users who did show correlations between beliefs and knowledge.
CONCLUSION: These data suggest that the differences in safety beliefs about CE between users and non-users do not stem from use of different information sources or more accurate safety knowledge.

Entities:  

Year:  2021        PMID: 33508011      PMCID: PMC7842904          DOI: 10.1371/journal.pone.0244865

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  36 in total

1.  Alertness drug arouses fears about 'lifestyle' misuse.

Authors:  Jim Giles
Journal:  Nature       Date:  2005-08-25       Impact factor: 49.962

2.  Professor's little helper.

Authors:  Barbara Sahakian; Sharon Morein-Zamir
Journal:  Nature       Date:  2007-12-20       Impact factor: 49.962

3.  Modelling predictors of UK undergraduates' attitudes towards smart drugs.

Authors:  Jacqueline Champagne; Benjamin Gardner; Eleanor J Dommett
Journal:  Trends Neurosci Educ       Date:  2019-02-06

4.  Attitudes Toward Cognitive Enhancer Use Among New Zealand Tertiary Students.

Authors:  Sanyogita Sanya Ram; Safeera Hussainy; Marcus Henning; Kay Stewart; Maree Jensen; Bruce Russell
Journal:  Subst Use Misuse       Date:  2017-04-21       Impact factor: 2.164

5.  Australian university students' attitudes towards the use of prescription stimulants as cognitive enhancers: perceived patterns of use, efficacy and safety.

Authors:  Brad Partridge; Stephanie Bell; Jayne Lucke; Wayne Hall
Journal:  Drug Alcohol Rev       Date:  2012-11-01

6.  Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany.

Authors:  A G Franke; C Bonertz; M Christmann; M Huss; A Fellgiebel; E Hildt; K Lieb
Journal:  Pharmacopsychiatry       Date:  2010-12-15       Impact factor: 5.788

Review 7.  Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature.

Authors:  Timothy E Wilens; Lenard A Adler; Jill Adams; Stephanie Sgambati; John Rotrosen; Robert Sawtelle; Linsey Utzinger; Steven Fusillo
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-01       Impact factor: 8.829

8.  What users think about the differences between caffeine and illicit/prescription stimulants for cognitive enhancement.

Authors:  Andreas G Franke; Klaus Lieb; Elisabeth Hildt
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

9.  Evaluating the drivers of and obstacles to the willingness to use cognitive enhancement drugs: the influence of drug characteristics, social environment, and personal characteristics.

Authors:  Sebastian Sattler; Guido Mehlkop; Peter Graeff; Carsten Sauer
Journal:  Subst Abuse Treat Prev Policy       Date:  2014-02-01

10.  Pharmacological cognitive enhancement: treatment of neuropsychiatric disorders and lifestyle use by healthy people.

Authors:  Barbara J Sahakian; Sharon Morein-Zamir
Journal:  Lancet Psychiatry       Date:  2015-03-31       Impact factor: 27.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.